A quality program includes structured dietary guidance, access to prescribers for dose adjustment requests between scheduled follow-ups, and explicit protocols for managing the three most common treatment obstacles: early-phase nausea severe enough to disrupt daily function, weight loss plateaus at 812 weeks despite medication adherence, and the transition period when patients approach goal weight and begin considering maintenance dosing or discontinuation
Yesour GLP-1 programs use semaglutide (same active ingredient as Ozempic/Wegovy) and tirzepatide (same as Mounjaro/Zepbound)
The addressable market for Wegovy and similar GLP-1 drugs is premium-priced and large
Breathing Mechanics & Abdominal Adiposity Jones, R
Switching from injectable semaglutide to methylcobalamin ODT Patients switching from injectable semaglutide to the methylcobalamin ODT formulation face a dosing conversion challenge
Both Wegovy and Ozempic contain the GLP-1 agonist semaglutide, but Wegovy is prescribed for long-term weight management and certain forms of liver disease, while Ozempic is used to control blood sugar in type 2 diabetes and help protect the heart and kidneys
